José María
López-Picazo González
Consultor Médico
José María López-Picazo González-rekin lankidetzan egindako argitalpenak (9)
2021
-
Paradigms on immunotherapy combinations with chemotherapy
Cancer Discovery, Vol. 11, Núm. 6, pp. 1353-1367
2017
2013
-
Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy
Journal of Translational Medicine, Vol. 11, Núm. 1
2007
-
Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer
Clinical and Translational Oncology, Vol. 9, Núm. 9, pp. 596-602
2005
-
Initial results of a prospective clinical study of cisplatin/paclitaxelbased hyperfiractionated chemoradiation (3DCRTHF) in squamous cell head and neck cancer (HNC) stages III-IV
EJC SUPPLEMENTS
-
Radiation pneumonitis following combined modality therapy in the treatment of locally advanced non-small cell lung cancer (LAD-NSCLC) including three-dimensional conformal radiation therapy (3D-CRT):: analysis of clinical and dosimetric prognostic factors
EJC SUPPLEMENTS
-
Three-dimensional conformal radiation therapy (3D-CRT) in the treatment of locally advanced non-small cell lung cancer (LAD-NSCLC):: Influence of clinical and dosimetric parameters on patterns of failure and survival
EJC SUPPLEMENTS
-
Three-dimensional conformal radiation therapy (3D-CRT) in the treatment of locally advanced non-small cell lung cancer (LAD-NSCLC):: Influence of clinical and dosimetric parameters on patterns of failure and survival
EJC SUPPLEMENTS
2001
-
Effect of PSA nadir and the time to nadir in the disease-free period in localized prostatic carcinoma treated with radical radiation
Revista de medicina de la Universidad de Navarra, Vol. 45, Núm. 1, pp. 20-28